Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
733.51
+8.64 (+1.19%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,009,365
Open
723.48
Bid (Size)
733.17 (3)
Ask (Size)
734.99 (1)
Prev. Close
724.87
Today's Range
721.00 - 737.45
52wk Range
392.25 - 800.78
Shares Outstanding
N/A
Dividend Yield
0.62%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Viking Therapeutics Incredibly Undervalued?
Today 10:30 EDT
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Via
The Motley Fool
Forget Nvidia, These Unstoppable Stocks Are Better Buys
April 27, 2024
These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence.
Via
The Motley Fool
Performance
YTD
+23.86%
+23.86%
1 Month
-5.71%
-5.71%
3 Month
+13.72%
+13.72%
6 Month
+29.66%
+29.66%
1 Year
+85.30%
+85.30%
More News
Read More
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
April 27, 2024
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/22 - 4/26
April 27, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Market Whales and Their Recent Bets on LLY Options
April 23, 2024
Via
Benzinga
SPDR ETF Report For Friday, April 26
April 27, 2024
Via
Talk Markets
Topics
ETFs
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
April 26, 2024
Via
Benzinga
Topics
Economy
Exposures
Economy
Interest Rates
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
April 26, 2024
Via
Investor's Business Daily
Dividend Legends: 3 Stocks With Over 100 Years of Payouts
April 25, 2024
Via
InvestorPlace
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
Via
Investor's Business Daily
Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
April 25, 2024
Via
InvestorPlace
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
April 24, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
Via
Benzinga
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
April 24, 2024
Via
The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
REITs Q1 Earnings Begin On Solid Note
April 23, 2024
Via
Benzinga
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
April 22, 2024
Via
Benzinga
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
April 22, 2024
Via
InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
6 Stocks Positioned to Soar as Investors Focus on MASH
April 22, 2024
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.